Company Filing History:
Years Active: 2021-2025
Title: Dana C Baiu: Innovator in Pediatric Oncology
Introduction
Dana C Baiu is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of pediatric oncology through her innovative research and development of targeted treatments for pediatric solid tumors. Her work focuses on the use of phospholipid ether analogs, which have the potential to improve the detection and treatment of malignant tumors in children.
Latest Patents
Dana C Baiu holds a patent for "Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors." This patent discloses that certain alkylphosphocholine analogs are preferentially taken up by malignant pediatric tumor cells. The alkylphosphocholine analogs are compounds that can be used to treat pediatric solid tumors or to detect them. In therapeutic applications, these compounds can include a radioactive iodine isotope that delivers localized radiation to the tumor cells. In detection and imaging applications, they can incorporate a detection moiety, such as a fluorophore or a radioactive iodine isotope.
Career Highlights
Dana has made remarkable strides in her career, particularly through her work at the Wisconsin Alumni Research Foundation. Her innovative approach to pediatric oncology has garnered attention and respect within the scientific community. With her patent, she has opened new avenues for research and treatment options for children suffering from solid tumors.
Collaborations
Dana has collaborated with notable colleagues, including Mario Otto and Bryan P Bednarz. These partnerships have further enhanced her research and contributed to the advancement of pediatric cancer treatment.
Conclusion
Dana C Baiu is a trailblazer in the field of pediatric oncology, with her innovative patent paving the way for improved treatment and detection of pediatric solid tumors. Her contributions are vital in the ongoing fight against cancer in children, and her work continues to inspire future innovations in the field.